MedTrace Logo

Evaluation of the Effectiveness of Vitamin D Supplementation to Pregnant Women and Their Infants in Pakistan.

NCT01229189 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 460

Last updated 2012-03-08

No results posted yet for this study

Summary

Vitamin D deficiency is wide spread in South Asian population and is contributing to burden of disease in this region including Pakistan. The relative importance of vitamin D deficiency, mutation in its receptor and maternal and child health has not been established in Pakistan and population based studies are required to explore and avert the maternal and Neonatal complications and consequences of Vitamin D deficiency

The trial will evaluate the effectiveness of Vitamin D supplementation to pregnant women and their Infants. It will be a double blind placebo controlled trial, which will be conducted in a rural district of Pakistan.

Conditions

Interventions

DIETARY_SUPPLEMENT

Vitamin D

Maternal dose of 4000 IU daily for 20 weeks Neonatal dose of 400 IU daily for 24 weeks

DIETARY_SUPPLEMENT

Placebo

Placebo will be supplemented to pregnant women and their neonates in the same pattern as in intervention group.

Sponsors & Collaborators

  • John Snow, Inc.

    collaborator INDUSTRY

  • Aga Khan University

    lead OTHER

Principal Investigators

  • Zulfiqar A Bhutta, FRCPCH, PhD · Aga Khan University

Study Design

Allocation
RANDOMIZED
Purpose
HEALTH_SERVICES_RESEARCH
Masking
QUADRUPLE
Model
SINGLE_GROUP

Eligibility

Min Age
15 Years
Max Age
49 Years
Sex
FEMALE
Healthy Volunteers
No

Timeline & Regulatory

Start
2010-02-28
Primary Completion
2011-08-31
Completion
2011-08-31

Countries

  • Pakistan

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT01229189 on ClinicalTrials.gov